EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression of full-length dystrophin reverses muscular dystrophy defects in young and old mdx4cv mice

Hichem Tasfaout, Timothy S McMillen, Theodore R Reyes, Christine L Halbert, Rong Tian, Michael Regnier, Jeffrey S Chamberlain

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci189075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Hichem Tasfaout und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and. Hauptthemen laut MEDLINE: Dystrophin, Muscular Dystrophy, Duchenne, Genetic Therapy, Muscular Dystrophy, Animal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gene replacement therapies mediated by adeno-associated viral (AAV) vectors represent a promising approach for treating genetic diseases. However, their modest packaging capacity (~4.7 kb) remains an important constraint and significantly limits their application for genetic disorders involving large genes. A prominent example is Duchenne muscular dystrophy (DMD), whose protein product dystrophin is generated from a 11.2 kb segment of the DMD mRNA. Here, we explored methods that enable efficient expression of full-length dystrophin via triple AAV codelivery. This method exploits the protein trans -splicing mechanism mediated by split inteins. We identified a combination of efficient and specific split intein pairs that enabled the reconstitution of full-length dystrophin from 3 dystrophin fragments. We show that systemic delivery of low doses of the myotropic AAVMYO1 in mdx 4cv mice led to efficient expression of full-length dystrophin in the hind limb, diaphragm, and heart muscles. Notably, muscle morphology and physiology were significantly improved in triple-AAV–treated mdx 4cv mice versus saline-treated controls. This method shows the feasibility of expressing large proteins from several fragments that were delivered using low doses of myotropic AAV vectors. It can be adapted to other large genes involved in disorders for which gene replacement remains challenged by the modest AAV cargo capacity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DystrophinMuscular Dystrophy, DuchenneGenetic TherapyMuscular Dystrophy, AnimalAnimalsMiceMice, Inbred mdxDependovirusHumansGenetic VectorsMuscle, Skeletal

Stichwörter der Autor:innen

Gene therapyGenetic diseasesGeneticsMuscle biologySkeletal muscleTherapeutics

Substanzen

DystrophinDmd protein, mouse

Autor:innen und Institutionen

  • Department of Neurology and.
  • Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center, University of Washington School of Medicine, Seattle, Washington, USA.
  • Department of Bioengineering, College of Engineering and School of Medicine, University of Washington, Seattle, Washington, USA.
  • Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Mitochondria and Metabolism Center and.
  • Center for Translational Muscle Research, University of Washington, Seattle, Washington, USA.

Förderung

  • NIAMS NIH HHS
  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • Muscular Dystrophy Association
  • Association Française contre les Myopathies
  • Diabetes Research Center
  • Wellstone Center at the University of Washington
  • US Department of Defense

Zitieren

APA

Tasfaout, H., McMillen, T. S., Reyes, T. R., Halbert, C. L., Tian, R., Regnier, M., & Chamberlain, J. S. (2025). Expression of full-length dystrophin reverses muscular dystrophy defects in young and old mdx4cv mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci189075

Vancouver

Tasfaout H, McMillen TS, Reyes TR, Halbert CL, Tian R, Regnier M, et al. Expression of full-length dystrophin reverses muscular dystrophy defects in young and old mdx4cv mice. Journal of Clinical Investigation. 2025. doi:10.1172/jci189075

BibTeX
@article{Tasfaout2025,
  author = {Tasfaout, Hichem and McMillen, Timothy S and Reyes, Theodore R and Halbert, Christine L and Tian, Rong and Regnier, Michael and Chamberlain, Jeffrey S},
  title = {Expression of full-length dystrophin reverses muscular dystrophy defects in young and old mdx4cv mice},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci189075}
}
Kostenlos starten →